GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Equity-to-Asset

Hansoh Pharmaceutical Group Co (HKSE:03692) Equity-to-Asset : 0.78 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Hansoh Pharmaceutical Group Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$28,214 Mil. Hansoh Pharmaceutical Group Co's Total Assets for the quarter that ended in Dec. 2023 was HK$36,137 Mil. Therefore, Hansoh Pharmaceutical Group Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.78.

The historical rank and industry rank for Hansoh Pharmaceutical Group Co's Equity-to-Asset or its related term are showing as below:

HKSE:03692' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.29   Med: 0.75   Max: 0.86
Current: 0.78

During the past 8 years, the highest Equity to Asset Ratio of Hansoh Pharmaceutical Group Co was 0.86. The lowest was 0.29. And the median was 0.75.

HKSE:03692's Equity-to-Asset is ranked better than
78.77% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs HKSE:03692: 0.78

Hansoh Pharmaceutical Group Co Equity-to-Asset Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Equity-to-Asset Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.67 0.86 0.74 0.76 0.78

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.73 0.76 0.76 0.78

Competitive Comparison of Hansoh Pharmaceutical Group Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansoh Pharmaceutical Group Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Hansoh Pharmaceutical Group Co's Equity-to-Asset falls into.



Hansoh Pharmaceutical Group Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Hansoh Pharmaceutical Group Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=28213.778/36137.447
=0.78

Hansoh Pharmaceutical Group Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=28213.778/36137.447
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hansoh Pharmaceutical Group Co  (HKSE:03692) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Hansoh Pharmaceutical Group Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines